Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $90.77 ($590K) on 2016-09-21, disclosed to the SEC on 2016-09-23.
Scheduled sale ($590k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.73 | 1,900 | $170K | 28.9% |
| 2 | $90.77 | 2,500 | $227K | 38.4% |
| 3 | $91.82 | 1,900 | $174K | 29.6% |
| 4 | $92.31 | 200 | $18K | 3.1% |
| Total | $90.82 avg | 6,500 | $590K | 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |